Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Clinical trial NCT03524326 · COMPLETED

Trial details

NCT number: NCT03524326
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma Head and Neck Cancer Head and Neck Carcinoma

Start date: 2018-04-30
Primary completion: 2022-10-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.